A treatment approach for smokers who also struggle with alcohol use.
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder
This study is looking at a new way to help people who smoke and struggle with drinking by rewarding them for drinking less while also giving them medication to help quit smoking, so they can tackle both challenges at the same time and hopefully feel better overall.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project ID | NIH-11079452 on NIH RePORTER |
What this research studies
This research investigates a new treatment method for individuals who smoke and have an alcohol use disorder. It utilizes a contingency management approach, which rewards participants for reducing their alcohol consumption, while they also receive medication to help them quit smoking. The study will measure the effectiveness of this combined treatment using urine tests to monitor alcohol levels. By focusing on both addictions simultaneously, the research aims to improve overall treatment outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who smoke and also have a diagnosed alcohol use disorder.
Not a fit: Patients who do not smoke or do not have an alcohol use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for individuals dealing with both smoking and alcohol addiction.
How similar studies have performed: Previous studies have shown promising results using contingency management for addiction treatment, suggesting this approach could be effective.
Where this research is happening
Pullman, United States
- Washington State University — Pullman, United States (Active)
Researchers
- Principal investigator: Mcpherson, Sterling M — Washington State University
- Study coordinator: Mcpherson, Sterling M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.